Real-Life Intracerebral Efficacy of Nivolumab in Non-Small Cell Lung Cancer Patients with Brain Metastases

被引：9
|
作者：
Geier, M. [1 ]
Descourt, R. [1 ]
Corre, R. [2 ]
Leveiller, G. [3 ]
Lamy, R. [4 ]
Goarant, E. [5 ]
Bizec, J. [6 ]
Bernier, C. [7 ]
Quere, G. [8 ]
Couturaud, F. [1 ]
Robinet, G. [1 ]
机构：
[1] Univ Hosp Brest, Dept Oncol, Chru Morvan, Brest, France
[2] CHU Rennes, Rennes, France
[3] Hosp St Brieuc, Dept Pulm Dis, Ch Yves Le Foll, St Brieuc, France
[4] Ctr Hosp Bretagne Sud Lorient, Lorient, France
[5] Hosp St Malo, Dept Pulm Dis, St Malo, France
[6] Hosp Vannes, Ch Bretagne Atlantique, Vannes, France
[7] Hosp Dinan, Ch Rene Pleven, Dinan, France
[8] Hop Morvan, Chru Brest, Brest, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
brain metastases; efficacy; Nivolumab;
D O I：
10.1016/j.jtho.2018.08.383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA08.10
引用
收藏
页码：S384 / S385
页数：2
相关论文
共 50 条
  • [21] EFFICACY OF PEMETREXED IN ADVANCED NON-SMALL CELL LUNG CANCER WITH ASYMPTOMATIC BRAIN METASTASES
    Kitai, Hidenori
    Asahina, Hajime
    Takashina, Taichi
    Ikezawa, Yasuyuki
    Sakakibara-Konishi, Jyunn
    Shinagawa, Naofumi
    Oizumi, Satoshi
    Nishimura, Masaharu
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S867 - S867
  • [22] FACTORS PREDICTING BRAIN METASTASES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hsiao, S.
    Chung, C.
    Liu, H. E.
    ANNALS OF ONCOLOGY, 2012, 23 : 428 - 429
  • [23] Platelet indices in non-small cell lung cancer patients with brain metastases
    Li, Ming-Ming
    Wang, Xin
    Yun, Zhi-Yuan
    Wang, Rui-Tao
    Yu, Kai-Jiang
    CANCER BIOMARKERS, 2019, 24 (04) : 515 - 519
  • [24] Multimodality management of non-small cell lung cancer patients with brain metastases
    Ricciardi, Serena
    de Marinis, Filippo
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (02) : 86 - 93
  • [25] The risk factors for brain metastases in patients with non-small cell lung cancer
    Lim, Jun Hyeok
    Um, Sang-Won
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [26] Treatment options for brain metastases in patients with non-small cell lung cancer
    Sadaf Taimur
    Martin J. Edelman
    Current Treatment Options in Oncology, 2003, 4 (1) : 89 - 95
  • [27] SURVIVAL OF PATIENTS WITH BRAIN METASTASES AND NON-SMALL CELL LUNG CANCER (NSCLC)
    Randhawa, J. K.
    Patel, S. P.
    Stokes, T. C.
    THORAX, 2009, 64 : A148 - A148
  • [28] The management of brain metastases in non-small cell lung cancer
    Owen, Scott
    Souhami, Luis
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [29] Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression.
    Corny, Jennifer
    Costantini, Adrien
    Renet, Sophie
    Fallet, Vincent
    Jouveshomme, Stephane
    Leprieur, Etienne Giroux
    Duchemann, Boris
    Selvarathnam, Shobanya
    Beaussier, Helene
    Brosseau, Solenn
    Hajouiji, Linda
    Taillade, Laurent
    Doucet, Ludovic
    Zalcman, Gerard
    Friard, Sylvie
    Tredaniel, Jean
    Wislez, Marie
    Jardin, Meryam
    Cadranel, Jacques
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Gene expression (GE)-based biomarkers associated with nivolumab response in a real-life cohort of patients with metastatic non-small cell lung cancer (mNSCLC)
    Radosevic-Robin, N.
    Ong, S.
    Warren, S. E.
    Kossai, M.
    Godfraind, C.
    Masson, M.
    Janicot, H.
    Merle, P.
    Dubray-Longueras, P.
    Durando, X.
    Morel, P.
    Cesano, A.
    Penault-Llorca, F.
    ANNALS OF ONCOLOGY, 2018, 29
12345